MedTech Dive July 30, 2024
Nick Paul Taylor

The digital health leaders detailed a seven-stage diagram for how the healthcare industry could monitor artificial intelligence software development.

Dive Brief:

  • Food and Drug Administration officials have outlined how lifecycle management could address the challenges of generative artificial intelligence in healthcare.
  • In a blog post published Thursday, leaders from the FDA’s Digital Health Center of Excellence (DHCoE) shared their work to map the AI lifecycle and identify key activities at each step in the process.
  • The authors see the model as a playbook for helping to assess standards and a launchpad for other projects, such as the development of a checklist for the systematic creation and evaluation of AI.

Dive Insight:

Troy Tazbaz, director of the DHCoE, and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, FDA, Govt Agencies, Technology
Generative AI Is Helping To Clear Up Brain Fog
Getting started with AI agents (part 1): Capturing processes, roles and connections
Unlocking The Genetic Code: AI Reveals New Insights Into Psychiatric Disorders
5 questions for the Abundance Institute's Neil Chilson
AI agents are unlike any technology ever

Share This Article